There are reports of FDA approval for a drug to treat a liver disease, with some outlets specifying the disease as MASH and others as NASH. Madrigal and Novo are mentioned as companies involved in the development of these drugs, with Madrigal's drug being referred to as Rezdiffra in some reports. It is unclear which company's drug was the first to receive approval, as different outlets provide conflicting information.